Momelotinib API is a JAK1/JAK2 and ACVR1 inhibitor developed for the treatment of myelofibrosis, helping reduce anemia and disease-related symptoms.

Momelotinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.